IL33 and acute myeloid leukemia: These data indicated that IL1RL1 and IL-33 is overexpressed in total leukemic cells, LSCs, and primitive LSCs, and their expression induced changes in the immune microenvironment landscape, and correlated with poor AML prognosis requiring further investigation of the IL-33/IL1RL1 axis in leukemogenesis and immunity.